Keyword: Arbor Pharmaceuticals
Arbor Pharmaceuticals' tipoff for consumer marketing enlists former NBA basketball star Shaquille O’Neal as frontman for longtime heart failure drug BiDil.
Takeda won FDA approval for blood pressure compound azilsartan, known as Edarbi, back in 2011, thumping meds like Diovan from Novartis and Daiichi Sankyo's Benicar in trials on the way to its green light. It's still a key seller in Japan for Takeda.
Zai Lab filed for a $115 million Nasdaq IPO, Takeda formed an R&D deal with Stanford, Fosun and Shanghai Pharma aim to buy a stake in Arbor, and more.
Fosun Pharma and Shanghai Pharma are bidding for a stake in U.S. drugmaker Arbor Pharma.